Literature DB >> 9596132

Reactive oxygen species in acute lung injury.

F Chabot1, J A Mitchell, J M Gutteridge, T W Evans.   

Abstract

The acute respiratory distress syndrome (ARDS) in adults is associated with a wide variety of precipitating factors, often not directly involving the lung, and has an associated mortality of 50-80%. ARDS is almost invariably associated with sepsis, either as an initiating factor or as a secondary complication, which increases the expression of a number of cytokines impacting upon several cellular systems. Specifically, activation of neutrophils sequestered in the pulmonary circulation by this process, causes the release of free radicals and reactive oxygen species (ROS), increasingly regarded as key substances modulating the endothelial dysfunction and disruption responsible for the principal clinical manifestations of the syndrome. Here we discuss briefly the pathophysiology of ARDS and its impact upon pulmonary vascular control; the biological origins of free radicals and other ROS involved, the mechanisms of their damaging effects, their contribution to the modification of pulmonary vascular control mechanisms in lung injury and possible therapeutic perspectives.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9596132

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  101 in total

1.  cGMP increases antioxidant function and attenuates oxidant cell death in mouse lung microvascular endothelial cells by a protein kinase G-dependent mechanism.

Authors:  R Scott Stephens; Otgonchimeg Rentsendorj; Laura E Servinsky; Aigul Moldobaeva; Rachel Damico; David B Pearse
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-05-07       Impact factor: 5.464

Review 2.  The pulmonary physician in critical care * 7: ventilator induced lung injury.

Authors:  T Whitehead; A S Slutsky
Journal:  Thorax       Date:  2002-07       Impact factor: 9.139

Review 3.  The pulmonary physician in critical care - part 9: non-ventilatory strategies in ARDS.

Authors:  J Cranshaw; M J D Griffiths; T W Evans
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

4.  Role of leptin as antioxidant in obstructive sleep apnea: an in vitro study using electron paramagnetic resonance method.

Authors:  Madalina Macrea; Thomas Martin; Leon Zagrean; Zhenquan Jia; Hara Misra
Journal:  Sleep Breath       Date:  2012-02-04       Impact factor: 2.816

5.  Acute lung inflammation in Klebsiella pneumoniae B5055-induced pneumonia and sepsis in BALB/c mice: a comparative study.

Authors:  Vijay Kumar; Sanjay Chhibber
Journal:  Inflammation       Date:  2011-10       Impact factor: 4.092

Review 6.  [Emergency treatment of thoracic trauma].

Authors:  U Klein; R Laubinger; A Malich; A Hapich; W Gunkel
Journal:  Anaesthesist       Date:  2006-11       Impact factor: 1.041

7.  Genetic and pharmacologic evidence links oxidative stress to ventilator-induced lung injury in mice.

Authors:  Srinivas Papaiahgari; Adi Yerrapureddy; Swetha R Reddy; Narsa M Reddy; Jeffery M Dodd-O; Michael T Crow; Dimitry N Grigoryev; Kathleen Barnes; Rubin M Tuder; Masayuki Yamamoto; Thomas W Kensler; Shyam Biswal; Wayne Mitzner; Paul M Hassoun; Sekhar P Reddy
Journal:  Am J Respir Crit Care Med       Date:  2007-09-27       Impact factor: 21.405

8.  Role of the endothelium and nitric oxide synthases in modulating superoxide formation induced by endotoxin and cytokines in porcine pulmonary arteries.

Authors:  S Muzaffar; J Y Jeremy; G D Angelini; K Stuart-Smith; N Shukla
Journal:  Thorax       Date:  2003-07       Impact factor: 9.139

9.  Role of IQGAP1 in endothelial barrier enhancement caused by OxPAPC.

Authors:  Yufeng Tian; Xinyong Tian; Grzegorz Gawlak; Nicolene Sarich; David B Sacks; Anna A Birukova; Konstantin G Birukov
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-08-26       Impact factor: 5.464

10.  Increased blood carboxyhaemoglobin concentrations in inflammatory pulmonary diseases.

Authors:  H Yasuda; M Yamaya; M Yanai; T Ohrui; H Sasaki
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.